Cabozanix 20 mg (Cabozantinib)
Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and Metastatic Thyroid Cancer.
Description
Cabozantinib is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and Metastatic Thyroid Cancer.
Product Features:
Product Name : Cabozanix
Generic Name :Cabozantinib
Formulation: Tablet
Available Pack Size: 90’s Pot & 30’s Pot
Available Strengths: 20 mg
Categories: Anti-viral, Biotech Products, Drugs to treat Hepatitis
Manufacturer: Beacon Pharmaceuticals Ltd.
Indications
Cabozantinib is a kinase inhibitor indicated for the treatment of-
Patients with advanced renal cell carcinoma (RCC)
Patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib
Storage Conditions:
Store Cabozantinib at room temperature 20°C to 25°C
Reviews
There are no reviews yet.